In today’s Pharmaceutical Executive Daily, we report on new data showing Wegovy’s potential to reduce liver injury in patients with MASH, Eli Lilly’s latest strategic collaborations in gene therapy, ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...

P opular weight-loss drugs known as GLP-1s could soon become more affordable for Americans. On Thursday, the Trump ...

It’s impossible to avoid headlines about GLP-1 medications. The weight-loss drugs target hormones in the gut and brain that ...

The Trump administration on Thursday announced its newest pharmaceutical agreement under its Most Favored Nation (MFN) policy, striking deals with Novo Nordisk and Eli Lilly to sell their GLP-1 ...

In an analysis of more than 6,800 colon cancer patients across all University of California Health sites, researchers found that those taking glucagon-like peptide-1 (GLP-1) medications were less than ...

There’s room for more than one winner in this race for GLP-1 weight loss supremacy, but some of these winners are going to be ...

So it was the government shutdown and some insane comments from OpenAI about a government backstop because of gigantic ...

Mid-market CFOs caught in a modernization gap, Senate votes to end government shutdown, Starbucks union plans strike.

Lucy D. Mastrandrea, MD, PhD, professor of pediatrics in the Jacobs School of Medicine and Biomedical Sciences, has been ...

Study also revealed no increased risk for major adverse cardiovascular events for patients on a GLP-1 RA versus those not on a GLP-1 RA.

UBS Global Healthcare Conference 2025 November 11, 2025 9:30 AM ESTCompany ParticipantsRobert McMahon - Senior ...